Article
Effect of hENT1 polymorphism G-706C on clinical outcomes of gemcitabine-containing chemotherapy for Chinese non-small-cell lung cancer patients.
Cancer epidemiology - 1 Dec 2014
Wu Fenglei, Zhang Jian, Hu Nan, Wang Huiyu, Xu Tongpeng, Liu Yi, Zheng Yitong
Abstract excerpt
AIM: To identify the single-nucleotide polymorphism (SNP) of hENT1 G-706C that is associated with response to gemcitabine-containing chemotherapy, and to determine the prognosis in patients with non-small-cell lung cancer (NSCLC). METHODS: Patients with stage III (A+B) or IV NSCLC were recruited for this study (n=225). Each subject received gemcitabine-containing chemotherapy. The association between human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
